Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in DCIS
23.10.2023
0:00
19:54
Interview with Seema A. Khan, MD, author of Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial. Hosted by Amalia Cochran, MD.
Related Content:
Weitere Episoden von „JAMA Surgery Author Interviews“
Verpasse keine Episode von “JAMA Surgery Author Interviews” und abonniere ihn in der kostenlosen GetPodcast App.